Sandrine Hayette

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Yves Chalandon, Xavier Thomas, Sandrine Hayette et al. · Blood · 2015 · 374 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

Philippe Rousselot, marie Magdelaine Coude, Nicola Gökbuget et al. · Blood · 2016 · 326 citations · Full text

Medicine, Hematology, Oncology +9

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association Group

Marie Balsat, Aline Renneville, Xavier Thomas et al. · Journal of Clinical Oncology · 2017 · 292 citations

Medicine, Hematology, Oncology +16

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet, Bruno Tesson, Jean‐Philippe Jais et al. · The Lancet Oncology · 2018 · 220 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression

François‐Xavier Mahon, Sandrine Hayette, Valérie Lagarde et al. · Cancer Research · 2008 · 210 citations

Medicine, Oncology, Pharmacology +14